ISG

Datum: 12-14/5/2016
Místo: Petrohrad, Rusko
Účastníci: 374

Hlavní témata

NAFLD and metabolic syndrome
Progress in therapeutic endoscopy
Inflammatory Bowel Disease
Diagnostic and therapeutic approaches in GERD
Hepatology
Colorectal malignancy

Akreditace

11. mezinárodní sympozium gastroenterologie (ISG) je akreditováno Evropskou akreditační radou pro dalšího vzdělávání ve zdravotnictví (EACCME) a poskytuje kontinuální vzdělávací programy CME pro zdravotnické odborníky. EACCME je instituce Evropské unie lékařských specialistů (UEMS).

11. mezinárodní sympozium gastroenterologie (ISG) je limitováno pro maximálně (nebo „ne více než“) 9 hodin evropských kreditů CME. Každý zdravotnický odborník si může nárokovat pouze hodiny kreditů skutečně strávené edukací.

ISG 2016

Ke stažení

Fotografie ze symposia

Opening session

Metabolic syndrome – Obesity as a risk factor for GI-disease development

Session I : NAFLD and comorbidity

Current approaches to diagnosis and treatment of NAFLD

NAFLD and alcoholic liver disease: Similarities and differences

Session II : Progress in therapeutic endoscopy

Endoscopic surgery – Emerging techniques which completely changed the current clinical practice

The European perspective of endoscopic submucosal dissection

Endoscopic diagnosis and tissue sampling in Barrett’s oesophagus

Is POEM a valid method for the treatment of achalasia patients?

Session III : Inflammatory bowel disease

Progress in conservative therapy in IBD

Can we use the aminosalicylates in clinical practice in IBD patients?

Laparoscopic procedures in IBD: Limits and advantages

Endoscopic surveillance of colorectal carcinoma and dysplasia in IBD patients

Functional GI disorders and IBD debut (clinical cases)

Session IV : Diagnostic and therapeutic approaches in GERD

Questions of diagnostics and treatment of different forms of GERD

GERD complications: Barrett’s metaplasia and others. Recommendation for clinical practice

GERD in patients with metabolic syndrome

Session V : Hepatology

Diagnostic and therapeutic possibilities in primary sclerosing cholangitis

Alcoholic liver diseases: Diagnostic and therapeutic possibilities

Session VI : Colorectal malignancy

Screening of colorectal carcinoma: Hot topics in current clinical gastroenterology

IBD as a risk factor for colorectal carcinoma. A real threat or more likely fiction at this time?

How to make the screening for colorectal carcinoma more effective